Fungal infection-related conditions and outcomes in severe COVID-19: a nationwide case-control study.

ABSTRACT:

Background

Fungal infections are significant complications of severe coronavirus disease 2019 (COVID-19). Although various risk factors for poor outcomes in patients with COVID-19 have been identified, clinical and treatment factors associated with fungal infections in patients with severe COVID-19 remain unclear. This study aimed to elucidate clinical factors associated with fungal infections during severe COVID-19 treatment.

Methods

This was a post hoc analysis of the J-RECOVER study, a multicenter retrospective observational study involving patients with COVID-19 who required admission at 66 hospitals between January and September 2020. Inclusion criteria were ages ≥ 18 years, COVID-19 diagnosis with reverse-transcription polymerase chain reaction, and treatment with mech

SUBMITTER: Maeshima K 

PROVIDER: S-EPMC11653589 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature